<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ911022-0172</DOCNO><DOCID>911022-0172.</DOCID><HL>   OTC Focus:   Index Drops 0.36% on Profit-Taking;   Traders Say Selling Pressure Isn't Strong   ----   By Dave Pettit   Staff Reporter of the Wall Street Journal</HL><DATE>10/22/91</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><IN>STOCK INDEXES (NDX)OTC GENERAL MARKET COMMENT (OTC)STOCK MARKET, OFFERINGS (STK)U.S. STOCK MARKET STATISTICS (STT)</IN><NS>STOCK AND OTHER INDEXES (NDX)STOCK andamp; OTHER MARKET NEWS (STK)</NS><RE>NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   NEW YORK -- Over-the-counter stocks fell modestlyyesterday on profit-taking that was inspired in part by thesagging bond market.   Nasdaq stocks spent the entire day lower but traders saidthe selling pressure wasn't strong. The Nasdaq CompositeIndex closed with a loss of 1.94, or 0.36%, to 536.96.Declining issues outnumbered advancers by just a 1,049-to-912margin.</LP><TEXT>   Trading activity moderated from its recent quick pace.National Market System volume totaled 124,530,000 shares,compared with 162,170,000 on Friday.   Prices were also weaker on the Big Board. The New YorkStock Exchange Composite Index fell 1.27, or 0.59%, while theDow Jones Industrial Average sank 16.77, or 0.54%.   Rising interest rates helped to set the negative tone forthe equity markets. Long-term U.S. government bonds fell bymore than 1 1/4 points, boosting the yield on the 30-yearTreasury to 8.065%.   While the prospect of further interest rate cuts by theFederal Reserve Board has helped to buoy stocks recently, JimBellini, director of equity trading at Dain Bosworth Inc.,said, &quot;There is talk going around today that this may be thelow point in rates.&quot;   William Sulya, head of OTC trading at A.G. Edwards andamp; Sons,said he saw profittaking among some investors but added thatmajor institutional investors didn't seem to be selling.   &quot;I haven't seen a tremendous amount of pressure on the OTCstocks,&quot; Mr. Sulya said. &quot;I don't see a trend in this and Idon't see any conviction on the downside.&quot;   A.G. Edwards' Mr. Sulya said he expects Nasdaq stocks torebound quickly from yesterday's weakness. Likewise, Mr.Bellini said he was encouraged about the market's prospectsbecause volume eased yesterday as prices fell.   Many of the market's prominent technology stocks droppeddespite a flurry of product introductions made in conjunctionwith the start of the Comdex trade show in Las Vegas, Nev.   Apple Computer, which unveiled notebook-size personalcomputers and a line of workstations, eased 1/4 to 54 3/4.Dell Computer, which introduced several portable computers,including one with a color screen, lost 1/2 to 29 3/4. LotusDevelopment, which rolled out an entry-level word-processingsoftware product, fell 1 to 28.   Meanwhile, Sun Microsystems sank 2 3/4 to 24 onNasdaq-leading volume of 4.7 million shares after analysts atGoldman Sachs and Dean Witter Reynolds made cautious commentsabout the stock. The workstation concern is expected toreport first-quarter earnings tomorrow. According to FirstCall, a unit of Thomson Financial Networks, the mean analystestimate for the quarter is 34 cents a share, compared withyear-ago net of 26 cents a share.   Aldus slipped 3/4 to 42 1/2. The developer of software forpersonal computers had third-quarter earnings of 35 cents ashare, off from last year's 45 cents. It said the resultswere depressed by greater-than-expected seasonal weakness inEurope.   Not all high-technology stocks were lower. Microsoft, themarket's largest issue in terms of capitalization, gained 1to 91. Oracle Systems rose 7/8 to 15 and BMC Software added1/2 to 54.   Oracle gained after Donaldson, Lufkin andamp; Jenrette analystScott Smith upgraded his rating on it to &quot;buy&quot; from&quot;moderately attractive,&quot; according to Dow Jones ProfessionalInvestor Report. The analyst said the software concern's&quot;solid cash flow and balance sheet performance foreshadow anearnings acceleration.&quot;   BMC Software jumped after it recorded net income of 42cents a share for its second quarter, ended Sept. 30, up from22 cents a share last year. Revenue rose to $43.8 millionfrom $29.3 million.   PictureTel advanced 2 1/2 to 40 1/2. The company enteredan agreement with International Business Machines to marketpersonal computers with videoconferencing capabilities.Compression Labs, a rival in the picture telephone business,eased 1/4 to 24 3/4.   Optical Radiation sank 2 3/4 to 21 1/4. The Food and DrugAdministration believes that two people may have become blindbecause they were treated with the company's Orcolon product.The jelly-like material is injected into the eye duringcertain surgeries, including cataract procedures.   Cognos dropped 3 to 14 1/4. Its chairman, Michael Potter,expects slower revenue growth to persist at the company forthe next one to three quarters, Dow Jones ProfessionalInvestor Report said.   U.S. Healthcare jumped 1 1/8 to 29 1/2 after the healthmaintenance organization operator reported third-quarter netof 54 cents a share, up from 27 cents last year. Revenueclimbed to $435.3 million from $334.9 million.   FHP International, another HMO concern, closed with a lossof 1/8 to 11 3/8, after trading as low as 10. It was named intwo lawsuits that allege it violated securities laws. Lastweek, the company estimated that its net for the firstquarter, ended Sept. 30, fell to 18 cents to 20 cents ashare, from 30 cents a year ago.   Minntech lost 3 3/4 to 13 3/4. The company posted netincome of 12 cents a share for its second quarter, endedSept. 30, above the 11 cents it earned last year but belowanalysts' estimates of 14 cents, according to ZacksInvestment Research.   Anergen continued to soar, gaining 4 1/4 to 20 1/4. Thebiotechnology concern had an initial public offering on Oct.10 at $8 a share. A spokesman said yesterday that he wasn'taware of any reason for the stock's gains.   BankWorcester rose 2 to 8 3/4. Its third-quarter earningsjumped to 36 cents a share from one cent a share last year.The company made a $2 million provision for loan losses inthe latest quarter, compared with a $3.4 million provision ayear ago.   Summit Health added 3/4 to 5 1/8 after it posted earningsof eight cents a share for its first quarter, ended Sept. 30,up from five cents a share last year.</TEXT></DOC>